An Important Update about Zantac
On April 1 2020, the U.S. Food and Drug Administration announced that it is requesting manufacturers to immediately withdraw all prescriptions and over-the-counter (OTC) ranitidine drugs from the market. This recall includes the well-known brand, Zantac. The medicines may contain low levels of a nitrosamine impurity called N-nitrosodimethylamine (NDMA), and the FDA has determined that the impurity may increase, which over time, leads to an unacceptable level of consumer exposure.
 
If you take Zantac speak with your physician about the best option for you or schedule an appointment at GI Associates by calling 877.442.7762.

Comments: